Page 147 - Materials Chemistry, Second Edition

128 Life Cycle Assessment of Wastewater Treatment

Common use of Production processes
pharmaceutical compounds

Human Farming Pharmaceutical
consumption industry

Pharmaceuticals
in water

Aerobic treatment
Biological Advanced
treatments oxidation processes
Anaerobic treatment

Hybrid technologies
advanced oxidation process + biological treatment

FIGURE 7.4 WWTP of pharmaceutical effluents.

• Disinfection and sterilization of resistant bioactive substances from
biotechnology.
• New crossover advancements specific to the pharmaceutical business. An
attempt is made here to talk about some of these issues with reference to
general procedure and particular cases.

The wastewater leaving pharmaceutical units varies in content and concentration,
and hence, we do not attempt a detailed treatment, since the volumes are small, and
distinctive compounds are made from a similar battery of reactors and separators.
Water reuse saves money through the reduction of waste transfer expenses and main-
tains the required water quality, balancing the operational expenses related to the
preparation of waste reuse.
The pharmaceutical business requires a steady supply of excellent-quality water
for generation and wastewater treatment to meet the requirements of ever-stricter
administrative release limits. To meet these difficulties, organizations must question
their customary intuitive and run-of-the-mill approaches and investigate new inno-
vations and answers to stay focused.
Thus, in the present chapter, we have endeavored to
• Understand the pathway of pharmaceutical waste, beginning at the business
site
• Group the specific mechanical procedures to handle waste in order
• Address the adequacy of cutting-edge methods and cross-breed innovations
for the removal of 200 pharmaceuticals from the water system

Pharmaceutical wastewater streams can be difficult to treat with conventional
physical/chemical and biological treatment systems. High chemical oxygen demand